Yatharth Hospital & Trauma Care Services Limited (YATHARTH)

About

Yatharth operates hospitals and trauma care services in India. FY26 (ended Jun 2026) standalone revenue ₹392.65 Cr with ₹45.42 Cr net profit, generating EPS ₹4.88. Market cap ₹8,142.91 Cr; small-cap operator with consistent 23% operating margins.

Face value: ₹10

Market cap

₹9,965 Cr

P/E

57.1×

P/B

5.5×

Dividend yield

0%

ROE

10%

ROCE

12.3%

Debt / equity

0.14

OPM

24.2%

EPS (TTM)

₹18.1

Book value

₹187.6

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

PE 46.68 high relative to current earnings; verify capex plans and volume trajectory justify valuation
ROE 9.98% trails operating margin of 24.2% — verify capex intensity, asset turnover, or balance-sheet structure explaining gap
Quarterly revenue lumpy (₹137–176 Cr per quarter vs ₹392.65 Cr annual run rate) — verify whether seasonal, mix-driven, or structural
Hospital sector subject to pricing regulation and billing scrutiny — verify exposure to margin compression or compliance costs

Generated analysis · source review pending

Growth drivers

Revenue grew 40% from ₹279.42 Cr to ₹392.65 Cr (Sep 2025–Jun 2026) — verify drivers: organic volumes, pricing, or mix
Operating margins 19.64–23.91% across quarters — verify whether variability is seasonal or margin-mix driven
D/E 0.14 very low; verify strategic use of balance-sheet capacity
EPS grew 14% from ₹4.28 to ₹4.88 (Sep 2025–Jun 2026) — verify drivers: volume, pricing, or margin expansion

Generated analysis · source review pending

774 historical price candles were omitted because the exchange source has not been verified.

₹1,033.7-6.7%1Y

Quick read

rule-based

Pros

+Healthy operating margin of 24.2%
+Profit CAGR of 37.1% over the last 3 years
+Revenue CAGR of 32.4% over the last 3 years
+Comfortable interest coverage of 35.2×

Cons

−Low dividend payout of 2.8% of profit
−Promoter holding fell 5.8 pts over the last year

Research score

Structured signal from quality, growth, valuation and momentum.

55/100

Business quality: 60
Growth: 84
Valuation

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Part ofNIFTY MICROCAP 250 NIFTY TOTAL MARKET

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Max Healthcare Institute LimitedMAXHEALTHMAXHEALTH	₹91,573 Cr	₹95,052 Cr	₹8,712 Cr	₹2,318 Cr	26.8%	₹1,457 Cr	17.2%	13.8%	14.3%	-110
Manipal Health Enterprises LimitedMANIPALHOSMANIPALHOS	₹91,552 Cr	₹1,02,105 Cr	₹10,336 Cr	₹2,611 Cr	25.3%	₹917 Cr	8.9%	12.5%	12.8%	38
Fortis Healthcare LimitedFORTISFORTIS	₹59,268 Cr	₹62,140 Cr	₹9,506 Cr	₹2,131 Cr	22.8%	₹1,048 Cr	11.7%	13%	11.1%	-99
Aster Dm Healthcare LimitedASTERDMASTERDM	₹36,728 Cr	₹37,429 Cr	₹4,876 Cr	₹958 Cr	19.4%	₹319 Cr	9.2%	11.9%	9.7%	-112
Global Health LimitedMEDANTAMEDANTA	₹36,498 Cr	₹37,688 Cr	₹4,683 Cr	₹979 Cr	20.8%	₹556 Cr	12.6%	16.9%	15.1%	-26
Narayana Hrudayalaya Ltd.NHNH	₹35,594 Cr	₹40,460 Cr	₹9,072 Cr	₹1,749 Cr	20.5%	₹816 Cr	10.2%	15.1%	19.7%	-181
Krishna Institute Of Medical Sciences LimitedKIMSKIMS	₹29,457 Cr	₹32,701 Cr	₹4,213 Cr	₹833 Cr	20.5%	₹205 Cr	6.2%	9.5%	11%	-50
Dr. Agarwal's Health Care LimitedAGARWALEYEAGARWALEYE	₹15,420 Cr	₹15,578 Cr	₹2,207 Cr	₹612 Cr	27.4%	₹148 Cr	8.1%	10.1%	6.8%	-76
Rainbow Childrens Medicare LimitedRAINBOWRAINBOW	₹13,003 Cr	₹13,003 Cr	₹1,820 Cr	₹575 Cr	32%	₹285 Cr	16.5%	18.2%	17.9%	-73
Park Medi World LimitedPARKHOSPSPARKHOSPS	₹11,696 Cr	₹11,924 Cr	₹1,679 Cr	₹444 Cr	26.5%	₹258 Cr	16.3%	21.4%	16.7%	-2
Healthcare Global Enterprises LimitedHCGHCG	₹9,984 Cr	₹10,895 Cr	₹2,627 Cr	₹480 Cr	18.3%	₹23 Cr	0.9%	9.1%	1.2%	-93
Yatharth Hospital & Trauma Care Services LimitedYATHARTHYATHARTH	₹9,965 Cr	₹10,218 Cr	₹1,334 Cr	₹310 Cr	24.2%	₹174 Cr	14.1%	12.3%	10%	-26

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	401	520	671	880	1,207
COGS	81	93	133	179	235
Gross profit	320	427	537	702	973
	209	294	357	482	680
	111	134	180	220	292
OPM %	27.6%	25.7%	26.8%	25%	24.2%
Depreciation	28	28	29	57	88
Interest	21	21	9	8	7
	2	3	16	16	26
Profit before tax	63	88	157	172	224
Tax	19	22	42	41	53
Tax %	30%	25%	27%	24%	23.8%
	44	66	114	131	170
PAT margin %	11%	12.6%	17.1%	14.8%	14.1%
EPS (₹)	6.8	10.1	14.5	14.7	18.2
EPS adjusted (₹)	6.8	10.1	13.3	13.6	17.7
Annual report	—	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	16	66	66	86	96	96
Reserves	—	51	117	788	1,509	1,711
Minority interest	—	—	—	—	32	—
	—	258	264	83	0	253
	—	51	39	62	94	221
Total equity & liabilities	—	426	486	1,019	1,731	2,282
	252	303	299	440	605	1,250
CWIP	—	—	—	0	222	102
Investments	—	0	0	1	74	2
	—	123	187	577	830	928
Total assets	—	426	486	1,019	1,731	2,282

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	60	64	-3	150	205
	-52	-20	-226	-420	-598
	-1	-18	304	520	254
Net cash flow	7	26	75	249	-140
Free cash flow	21	44	-96	-161	-112
CFO / Operating profit %	54.1%	47.7%	-1.7%	67.9%	70%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	79.7%	82.1%	80.1%	79.7%	80.6%
EBITDA margin %	27.6%	25.7%	26.8%	25%	24.2%
EBIT margin %	20.7%	20.4%	22.5%	18.5%	16.9%
PAT margin %	11%	12.6%	17.1%	14.8%	14.1%
Working capital
Receivable days	78	76	124	125	113
Inventory days	23	24	22	43	32
Payable days	92	66	80	60	171
NWC days	10	33	66	108	-26
Leverage
Current ratio	1.13	1.77	7.59	10.12	3.87
Debt to EBITDA	2.33	1.97	0.46	0	0.87
Debt to equity	2.21	1.44	0.09	0	0.14
Interest coverage	3.9	5.1	17.6	23.9	35.2
Asset turnover	0.94	1.07	0.66	0.51	0.53
Return ratios
Return on assets %	10.4%	13.5%	11.2%	7.5%	7.5%
Return on capital employed %	25.7%	30.5%	24.8%	13.8%	12.3%
Return on equity %	37.8%	35.9%	13.1%	8.1%	9.4%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	66.33%	66.44%	66.54%	66.54%	66.54%	61.44%	61.64%	61.64%	61.64%	55.8%	55.8%	55.8%
	5.42%	2.59%	3.99%	4.89%	6.28%	9.78%	4.45%	4.34%	6.5%	6.18%	5.25%	5.62%
	9.07%	8.81%	9.33%	9.41%	6.98%	11.5%	13.56%	13.52%	8.7%	11.01%	12%	10.84%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	19.18%	22.16%	20.14%	19.16%	20.2%	17.28%	20.35%	20.5%	23.16%	27.01%	26.95%	27.74%
No. of shareholders	—	—	—	—	—	—	—	—	91,434	96,221	99,117	96,264

Promoter holding down 10.53 percentage points since Sep 2023.

42 deals · 7 Aug 2023 – 14 Jul 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
14 Jul 2026	CLASSIC ENTERPRISES	Bulk	NSE	Sell	5,00,000	₹814.35	₹40.72 Cr
14 Jul 2026	HR GLOBAL MANUFACTURING PRIVATE LIMITED	Bulk	NSE	Buy	5,00,000	₹814.72	₹40.74 Cr
28 Nov 2025	NEENA TYAGI	Bulk	NSE	Sell	56,33,800	₹716.98	₹403.93 Cr
28 Nov 2025	MANSI SHARE AND STOCK BROKING PRIVATE LIMITED	Bulk	NSE	Sell	8,64,291	₹712.51	₹61.58 Cr
28 Nov 2025	MANSI SHARE AND STOCK BROKING PRIVATE LIMITED	Bulk	NSE	Buy	8,44,291	₹715.67	₹60.42 Cr
28 Nov 2025	KOTAK MAHINDRA MUTUAL FUND	Bulk	NSE	Buy	8,00,000	₹719.37	₹57.55 Cr
28 Nov 2025	SHARE INDIA SECURITIES LIMITED	Bulk	NSE	Buy	6,76,007	₹715.84	₹48.39 Cr
28 Nov 2025	SHARE INDIA SECURITIES LIMITED	Bulk	NSE	Sell	6,75,107	₹715.73	₹48.32 Cr
28 Nov 2025	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	5,78,010	₹719.44	₹41.58 Cr
28 Nov 2025	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	5,77,989	₹719.86	₹41.61 Cr

1–10 of 42

1 / 5

Mr. Ajay Kumar TyagiExecutive Director-Chairperson related to Promoter
Mr. Kapil KumarExecutive Director-MD
Mr. Yatharth TyagiExecutive Director
Mrs. Promila BhardwajNon-Executive - Independent Director
Mr. Mukesh SharmaNon-Executive - Independent Director
Mr. Sanjeev UpadhyayaNon-Executive - Independent Director
Mr. Ramesh KrishnanNon-Executive - Independent Director
Ritesh MishraCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

12

across 4 fund houses

Held by these funds

4.55%

of the company's equity

All mutual funds

9.74%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

12 schemes · 4 fund houses

		Shares
Portfolio of Kotak Multi Cap FundNEW	Kotak Mahindra Mutual Fund	31.53 L	315.89	1.03%	3.271%	—
IB29-Groww Multicap Fund	Groww Mutual Fund	3.22 L	32.27	2.19%	0.334%	+1.17 L
Portfolio of Kotak Special Opportunities Fund	Kotak Mahindra Mutual Fund	3.1 L	31.06	1.82%	0.322%	-0
Portfolio of Kotak Healthcare Fund	Kotak Mahindra Mutual Fund	2.49 L	24.95	3.25%	0.258%	-0
IB60-Groww Small Cap Fund	Groww Mutual Fund	1.76 L	17.63	2.31%	0.183%	+22,481
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	1.11 L	11.13	0.45%	0.115%	-2,433
IB63-Groww BSE Hospitals ETF	Groww Mutual Fund	28,375	2.84	1.79%	0.029%	+5,717
IB13-Groww Value Fund	Groww Mutual Fund	24,164	2.42	3.25%	0.025%	+11,104

1–8 of 12

1 / 2

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

30

Annual reports

3

Credit ratings

1

We hereby submit intimation for upgradation of Credit Rating of the Company by CRISIL Ratings Limited.6 Nov 2025 from CRISIL

Investor Presentation and earnings call

5

Aug 2026Transcript AI Summary PPT REC
May 2026Transcript AI Summary PPT

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Interim dividend14 Aug 2026 · ex-date₹0.5

1

Board meeting to consider results10 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

33 announcementsExport CSV

28 Sept 2026, 4:11 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

22 Sept 2026, 9:22 pmAGM/EGM

Shareholder Meeting - EGM On October 15, 2026

EGM PDF

17 Sept 2026, 4:59 pmCompany Update

Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

Amendments to Memorandum & Articles of Association PDF

17 Sept 2026, 2:47 pmCompany Update

Announcement under Regulation 30 (LODR)-Issue of Securities

Issue of Securities PDF

17 Sept 2026, 12:10 pmCompany Update

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release / Media Release PDF

17 Sept 2026, 12:02 pmBoard Meeting

Board Meeting Outcome for Outcome Of The Board Meeting

Outcome of Board Meeting PDF

14 Sept 2026, 3:45 pmBoard Meeting

Board Meeting Intimation for Issuance Of Equity Shares Or Other Securities.

Exchange filing PDF

14 Sept 2026, 3:02 pmCompany Update

Announcement Under Reg. 30(LODR)- Favourable Developments In Income Tax Proceedings.

General PDF

Date	Category	Subject	Filing
28 Sept 2026, 4:11 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
22 Sept 2026, 9:22 pm	AGM/EGM EGM	Shareholder Meeting - EGM On October 15, 2026	PDF

Loading announcements…

Yatharth Hospital & Trauma Care Services Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Events

1

1

Announcements

Not in the F&O segment

1

1

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Compounded sales growth

Compounded profit growth

Return on equity

Yatharth Hospital & Trauma Care Services Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Events

Dividends1

Board meetings1

Announcements

Ratio timeline

Not in the F&O segment

Dividends1

Board meetings1

Quarterly record

Bulk & block deals

Board and management

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

1

1

1

1